about
Human IFNAR2 deficiency: Lessons for antiviral immunityHost genetic factors in susceptibility to mycobacterial disease.Varicella zoster virus immunity: A primer.Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in TNFAIP3 (A20).Pyogenic Spondylodiscitis: Risk Factors for Adverse Clinical Outcome in Routine Clinical PracticeSevere type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2COVID-19 management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases centre: a detailed descriptive analysis
P50
Q28114888-F8244F63-1346-4AB3-856B-CCE226834FC7Q38282039-8100774A-70F2-431A-9790-CAE8671BFDC8Q38445442-885D2CB8-5D06-4ED6-AED9-75DF802E26B6Q47849296-B8AA02BE-2847-44D2-8C6D-D17DC4BC7141Q58097278-F5C2F597-542C-4BC8-8C6F-D73CF4E473DBQ91972380-E6011523-21AD-497C-B30B-299760A80028Q95603327-13731CFE-0190-4ECB-ACD0-F04618565E32
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christopher J. A. Duncan
@ast
Christopher J. A. Duncan
@en
Christopher J. A. Duncan
@es
Christopher J. A. Duncan
@nl
Christopher J. A. Duncan
@sl
type
label
Christopher J. A. Duncan
@ast
Christopher J. A. Duncan
@en
Christopher J. A. Duncan
@es
Christopher J. A. Duncan
@nl
Christopher J. A. Duncan
@sl
altLabel
Chris Duncan
@en
prefLabel
Christopher J. A. Duncan
@ast
Christopher J. A. Duncan
@en
Christopher J. A. Duncan
@es
Christopher J. A. Duncan
@nl
Christopher J. A. Duncan
@sl
P108
P1053
A-2018-2012
P106
P108
P21
P31
P3829
P496
0000-0003-4181-2315